Medical Device News Magazine

EchoNous Launches Continuous and Pulsed Wave Doppler on Kosmos Hand-Carried Hardware

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

EchoNous, developers of AI-driven, hand-carried ultrasound, today announced the addition of both continuous wave (CW) and pulsed wave (PW) Doppler capabilities to the Kosmos hardware platform, the company’s flagship offering.

This innovation represents an industry first for an ultra-mobile, ultrasound product; creating the first “hybrid” point-of-care ultrasound (POCUS) device, offering large machine-benchmarked ultrasound imaging and Doppler functionality in a hand-carried unit (HCU).

Designed as an all-in-one diagnostic tool that can be carried from bedside to bedside, Kosmos was developed with the essential technology necessary for highly sensitive CW and PW wave Doppler scanning already built-in notes EchoNous.

Kosmos units are now easily upgradeable over the air for the addition of CW and PW Doppler.

The inclusion of these tools rounds out Kosmos’s already comprehensive suite of diagnostic capabilities. This suite includes AI-assisted systolic heart function, which is derived from high-resolution imaging and enabled by a novel new algorithmic tool, ‘Trio.’

Prior to this launch, CW Doppler had historically eluded the HCU POCUS market. Kosmos’s hybrid approach is designed from the ground up based on specifications historically found on more expensive cart-based models.

Benchmarks include greater power, a high signal-to-noise ratio, and an increased channel count (64 channels). These features are all essential for high performance with increased sensitivity CW Doppler.

“We firmly believe that POCUS is the future of medicine and that HCU must be delivered on par with larger, more expensive machines – our tools should not be limited by their size,” explained Kevin Goodwin, CEO of EchoNous. “By removing these hurdles, we now offer diagnostic-grade capabilities to answer specific clinical questions for cardiologists and all clinician users; focused on upgrading bedside medicine with higher-performance tools that remain less expensive.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”